Medicinal, Not Alternative: Regulation, Access, and Safety in the Therapeutic Use of Cannabis Products in Brazil

Abstract

This perspective article offers a critical reflection on the regulatory, health, and social challenges related to the therapeutic use of cannabis-based products in Brazil. Through an analysis of the current regulatory framework and the implications of classifying these products outside the category of medicines, the article discusses the fragility of existing mechanisms for quality control, traceability, and pharmacovigilance. It also addresses existing gaps, the lack of structured public policies, and the barriers that compromise equitable access.